Skip to main content

Prognostic significance of minor versus major extranodal extension in oral cavity squamous cell carcinoma: a systematic review and meta-analysis

In brief

Major extranodal extension doubles death hazard in oral cancer

In a meta-analysis of surgically treated oral cavity cancers, major extranodal extension was associated with about twice the death hazard of minor extension, based on five studies. Disease-free survival showed a similar pattern, but estimates were imprecise; the 2-mm cutoff is clinically useful, not a definitive biological boundary.

Journal
Oral oncology (Q1)
Published
11 November 2026
Study design
Systematic review of cohort studies
Evidence level
Level 2, Moderate (CEBM 2a)
Authors
Luigi Angelo Vaira, Hareem Qadeer, Jerome R Lechien, Antonino Maniaci, Fabio Maglitto, Giovanni Salzano, et al.
PMID
43014091
DOI
10.1016/j.oraloncology.2026.108220

Why clinicians should know about it

  • Picked for Surgical Oncology (top studies of the week, 15 November 2026): Major ENE prognostic, informs margin decisions

Abstract

BACKGROUND: Extranodal extension (ENE) is an established adverse prognostic factor in oral cavity squamous cell carcinoma (OCSCC), but the clinical relevance of its extent remains uncertain. This systematic review and meta-analysis evaluated the prognostic impact of quantitatively defined minor versus major ENE, with particular emphasis on the conventional 2-mm threshold. METHODS: PubMed, Scopus, Embase, and the Cochrane Library were searched from inception to August 2026. Studies of surgically treated OCSCC assessing pathological ENE extent and oncological outcomes were included. Random-effects meta-analyses using restricted maximum likelihood and Hartung-Knapp inference were performed when at least three compatible adjusted hazard ratios (HRs) were available. Risk of bias was assessed using QUIPS. RESULTS: Twenty-two reports representing 18 independent cohorts were included. Five studies contributed to the primary overall survival (OS) meta-analysis. Major ENE was associated with significantly worse OS than minor ENE (pooled HR 2.01, 95% CI 1.10-3.66; I2 = 60.5%). Three studies contributed to the disease-free survival (DFS) meta-analysis, showing a concordant but imprecise association (pooled HR 2.16, 95% CI 0.44-10.66; I2 = 59.3%). Alternative thresholds and morphological classifications also generally suggested poorer outcomes with increasing ENE extent. CONCLUSIONS: ENE extent provides prognostic information beyond binary ENE status in OCSCC. Major ENE is associated with worse OS, while evidence for DFS is directionally consistent but less precise. The 2-mm cutoff should be considered clinically useful but not yet biologically definitive.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.